| Literature DB >> 35300703 |
Pablo Ruiz Cuenca1,2, Stephanie Key3, Kim A Lindblade4, Indra Vythilingam5, Chris Drakeley3, Kimberly Fornace3,6.
Abstract
BACKGROUND: The zoonotic malaria parasite Plasmodium knowlesi has emerged across Southeast Asia and is now the main cause of malaria in humans in Malaysia. A critical priority for P. knowlesi surveillance and control is understanding whether transmission is entirely zoonotic or is also occurring through human-mosquito-human transmission.Entities:
Keywords: Disease emergence; Macaques; Malaria; Non-zoonotic transmission; Plasmodium knowlesi; Simian malaria; Systematic literature review; Zoonoses
Mesh:
Year: 2022 PMID: 35300703 PMCID: PMC8929260 DOI: 10.1186/s12936-022-04110-z
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Evidence identified by the previous ERG, showing potential data sources and how each type of evidence would support or refute non-zoonotic transmission
Fig. 1Qualitative assessment of diagnostic methods to identify P. knowlesi infection in humans. PCR/LAMP are separated into two categories due to the reported cross-reactivity between P. vivax primers and P. knowlesi samples
Fig. 2Evidence and consistency statements and their relationship to confidence. Confidence increases towards the top-right corner as suggested by the increasing strength of shading
Fig. 3Number of references retrieved by year. Vertical dotted lines represent 2 key points in time: the first report of natural human infection with P. knowlesi and the identification of a P. knowlesi outbreak in Sarawak, Malaysian Borneo
Fig. 4PRISMA flow chart, indicating number of references included and excluded at various stages
Harvest plot indicating all papers that support or refute sustained human-mosquito-human transmission within each evidence category, with the corresponding reference numbers
Mixed infections reported in vector species, with numbers tested and numbers positive
| Infection | Tested | Positive | Refs. |
|---|---|---|---|
| Mixed human—zoonotic | |||
| 72 | 1 | [ | |
| 6134 | 21 | [ | |
| 80 | 8 | [ | |
| 6062 | 2 | [ | |
| 6062 | 1 | [ | |
| Other simian | |||
| 10 933 | 397 | [ | |
| 2937 | 4 | [ | |
| 8969 | 5 | [ | |
| 1482 | 4 | [ | |
| 1482 | 1 | [ | |
| 1482 | 1 | [ | |
Pk P. knowlesi,Pf P. falciparum, Pv P. vivax, Pcyn P. cynomolgi,Pin P. inui and Pct P. coatneyi are accounted for in these mixed infections
Mixed infections reported in humans
| Infection | Number | Diagnosis | Year | Refs. |
|---|---|---|---|---|
| India | ||||
| 1 | PCR | 2018 | [ | |
| 6 | PCR | 2018 | [ | |
| 6 | PCR | 2018 | [ | |
| Indonesia | ||||
| 97 | PCR | 2015 | [ | |
| 65 | PCR | 2015 | [ | |
| Malaysia | ||||
| 5 | PCR | 2004 | [ | |
| 1 | PCR | 2004 | [ | |
| 8 | PCR | 2004 | [ | |
| 6 | PCR | 2008 | [ | |
| 4 | PCR | 2008 | [ | |
| 1 | PCR | 2008 | [ | |
| 7 | PCR | 2008 | [ | |
| 3 | PCR | 2009 | [ | |
| 3 | PCR | 2009 | [ | |
| 86 | PCR | 2009 | [ | |
| 1 | PCR | 2010 | [ | |
| 1 | PCR | 2010 | [ | |
| 9 | PCR | 2011 | [ | |
| 36 | PCR | 2011 | [ | |
| 2 | PCR | 2011 | [ | |
| 2 | PCR | 2011 | [ | |
| 1 | PCR | 2011 | [ | |
| 1 | Sequencing | 2013 | [ | |
| 10 | Sequencing | 2013 | [ | |
| 3 | NM-PCR | 2014 | [ | |
| 6 | PCR | 2016 | [ | |
| 1 | PCR | 2016 | [ | |
| 6 | PCR | 2016 | [ | |
| 6 | Sequencing | 2017 | [ | |
| 12 | Sequencing | 2017 | [ | |
| 12 | Sequencing | 2017 | [ | |
| Myanmar | ||||
| 13 | Sequencing | 2008 | [ | |
| 2 | Sequencing | 2008 | [ | |
| 13 | Sequencing | 2008 | [ | |
| 1 | Sequencing | 2013 | [ | |
| Thailand | ||||
| 1 | PCR | 1996 | [ | |
| 5 | PCR | 2007 | [ | |
| 4 | PCR | 2007 | [ | |
| 6 | PCR | 2019 | [ | |
| 5 | PCR | 2019 | [ | |
| 4 | PCR | 2019 | [ | |
| Vietnam | ||||
| 1 | PCR | 2010 | [ | |
| 19 | PCR | 2010 | [ | |
| 12 | PCR | 2010 | [ | |
Pk P. knowlesi, Pf P. falciparum, Pv P. vivax, Po P. ovale, Pm P. malariae and Pcyn P. cynomolgi are accounted for in mixed infections
Main conclusions from identified literature with accompanying qualitative assessment of evidence
| Conclusion | Evidence |
|---|---|
| Experimental human-mosquito-human transmission has been demonstrated in laboratory settings | High consistency, limited evidence |
| Spatio-temporal clusters of human cases have been found which may be consistent with human-mosquito-human transmission but no quantitative analyses have been performed to confirm this | Medium consistency, limited evidence |
| Distribution of known natural hosts and vectors for | High consistency, robust evidence |
| No secondary | Medium consistency, limited evidence |
| The lack of | High consistency, limited evidence |
| Models suggest human-mosquito-human transmission is unlikely but still plausible within observed parameters | High consistency, medium evidence |
| Models suggest reproductive rates are highly sensitive to contact patterns between simian hosts, vectors and people as well as vector biting preferences and likely to be highly affected by land use change | High consistency, robust evidence |
| Mixed infections with | High consistency, robust evidence |
| High consistency, medium evidence | |
| Medium consistency, medium evidence | |
| Multiple invasion pathways have been identified, with a range of specific proteins aiding cell invasion. This shows there are no molecular barriers to invasion of human erythrocytes other than the requirement of Duffy antigens | High consistency, robust evidence |
| There are genetically distinct subpopulations of | Low consistency, medium evidence |
| There is no evidence of drug resistance in | High consistency, robust evidence |